Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England
Crossref DOI link: https://doi.org/10.1007/s40264-015-0384-7
Published Online: 2016-01-21
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McNaughton, Rhian
Lynn, Elizabeth
Osborne, Vicki
Coughtrie, Abigail
Layton, Deborah
Shakir, Saad
Funding for this research was provided by:
AstraZeneca
License valid from 2016-01-21